Douglas C. Bryant - 28 Feb 2023 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
President & CEO, Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Douglas C. Bryant
Issuer symbol
QDEL
Transactions as of
28 Feb 2023
Transactions value $
$0
Form type
4
Date filed
02 Mar 2023, 15:15
Previous filing
27 Feb 2023
Next filing
30 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units (Converted) Award $0 +10.7K $0.00 10.7K 28 Feb 2023 Common Stock 10.7K Direct F1, F2, F3
transaction QDEL Restricted Stock Units (Premium) Award $0 +3.27K $0.00 3.27K 28 Feb 2023 Common Stock 3.27K Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2 The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.
F3 The restricted stock units vested on February 28, 2023.
F4 The restricted stock units vest on February 28, 2024.